These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22096063)

  • 21. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.
    Goossens H; Ferech M; Coenen S; Stephens P;
    Clin Infect Dis; 2007 Apr; 44(8):1091-5. PubMed ID: 17366456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight.
    Adriaenssens N; Coenen S; Versporten A; Goossens H
    Int J Antimicrob Agents; 2013 Nov; 42(5):466-70. PubMed ID: 23993932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?
    Watier L; Cavalié P; Coignard B; Brun-Buisson C
    Euro Surveill; 2017 Nov; 22(46):. PubMed ID: 29162212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages.
    Bruyndonckx R; Hens N; Aerts M; Goossens H; Molenberghs G; Coenen S
    J Antimicrob Chemother; 2014 Jul; 69(7):1981-6. PubMed ID: 24623832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic consumption in southern and eastern Mediterranean hospitals: results from the ARMed project.
    Borg MA; Zarb P; Ferech M; Goossens H;
    J Antimicrob Chemother; 2008 Oct; 62(4):830-6. PubMed ID: 18593724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014-2018: Findings and Implications from ESAC-Net and WHO Europe.
    Robertson J; Vlahović-Palčevski V; Iwamoto K; Högberg LD; Godman B; Monnet DL; Garner S; Weist K; ;
    Front Pharmacol; 2021; 12():639207. PubMed ID: 34220495
    [No Abstract]   [Full Text] [Related]  

  • 27. [Surveillance of antibiotic resistance and antibiotic consumption in Medimurje].
    Payerl-Pal M
    Acta Med Croatica; 2004; 58(4):285-91. PubMed ID: 15700684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibiotic consumption between 1996 and 2003: national survey and international comparison].
    Benko R; Matuz M; Doró P; Hajdú E; Nagy G; Nagy E; Soós G
    Orv Hetil; 2006 Jul; 147(26):1215-22. PubMed ID: 16898083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional variation in outpatient antibiotic prescribing in Germany.
    Kern WV; de With K; Nink K; Steib-Bauert M; Schröder H
    Infection; 2006 Oct; 34(5):269-73. PubMed ID: 17033751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department.
    Borde JP; Kern WV; Hug M; Steib-Bauert M; de With K; Busch HJ; Kaier K
    Emerg Med J; 2015 Jul; 32(7):509-15. PubMed ID: 25261006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis.
    Faes C; Molenberghs G; Hens N; Muller A; Goossens H; Coenen S
    J Antimicrob Chemother; 2011 Dec; 66 Suppl 6():vi89-94. PubMed ID: 22096070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
    de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
    J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of non-hospital antibacterial pharmacotherapy in Poland.
    Dziurda D; Polak S; Skowron A; Kuschill-Dziurda J; Brandys J
    Int J Infect Dis; 2008 Sep; 12(5):483-9. PubMed ID: 18417399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci.
    Kolar M; Urbanek K; Vagnerova I; Koukalova D
    J Clin Pharm Ther; 2006 Feb; 31(1):67-72. PubMed ID: 16476122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data.
    Farooqui HH; Selvaraj S; Mehta A; Heymann DL
    PLoS One; 2018; 13(10):e0204805. PubMed ID: 30332450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe?
    Patrick DM; Marra F; Hutchinson J; Monnet DL; Ng H; Bowie WR
    Clin Infect Dis; 2004 Jul; 39(1):11-7. PubMed ID: 15206046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Problems in collecting comparable national drug use data in Europe: the example of antibacterials.
    Rønning M; Blix HS; Strøm H; Skovlund E; Andersen M; Stichele RV
    Eur J Clin Pharmacol; 2003 Apr; 58(12):843-9. PubMed ID: 12698312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.
    Goossens H; Ferech M; Vander Stichele R; Elseviers M;
    Lancet; 2005 Feb 12-18; 365(9459):579-87. PubMed ID: 15708101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
    Bamberger DM; Dahl SL
    Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.